Vivos Inc (RDGL): Cost of Revenue
$128.1K
Year ended 2025-12-31
$124.8K
Trailing 12 months to 2026-06-30
+64.5%
3-year compound annual growth
+87.0%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $128.1K | +313.6% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $31.0K | +21.3% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $25.5K | -11.3% | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | $28.8K | +139.8% | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | $12.0K | +114.0% | 2023-03-01, From 2021-01-01 |
| 2020-12-31 | $5.6K | -7.0% | 2022-03-07, From 2020-01-01 |
| 2019-12-31 | $6.0K | n/a | 2021-03-24, From 2019-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Vivos Inc (RDGL) | 2025-12-31 | $128.1K | +313.6% |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $287.0K | n/a |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $539.0K | n/a |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $222.4K | -77.7% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $646.0K | +139.3% |
| Flyte Aviation, Inc. (VJET) | 2025-12-31 | $63.0K | +50.0% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $557.0K | -31.3% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $327.0K | n/a |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $386.9K | +181.0% |
Compare RDGL, QTEX, PLSE, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗